Healthcare leaders must approach this moment not just as an opportunity to expand services, but as a chance to reshape patient trust, affordability, and long-term health outcomes
Is customer service responsive and technically knowledgeable
Thirdly, in rare cases, a sample can be incorrectly genotyped as HCV-1 by GT II, and consequently, the GT Plus returns a not detected result
Mounjaro has truly been a godsend
With 12 months of treatment in an open-label study, up to 12.5% (16/128) of EMGALITYtreated patients developed anti-galcanezumab-gnlm antibodies, most of whom tested positive for neutralizing antibodies
Future studies with large sample size and randomization can help in validating the findings of the current study